E-drug: Second Expression of Interest
-------------------------------------------------------------------------
[The url below is too long for one line and wraps to the next.
Please repair it when you paste it into the address line of your
browser. HH]
Dear E-druggers,
As part of efforts to dramatically increase access to and
affordability of HIV/AIDS-related care and treatment, WHO
(together with UNICEF, UNAIDS and UNFPA) are inviting
Expressions of Interest from manufacturers of pharmaceutical
products for the management of HIV-related diseases. The World
Bank supports this effort.
This second invitation aims to increase the range of possible
products and sources as a follow up to the first invitation of
October 2000.
The deadline for submissions is 01 October 2001, 12.00 noon
Central European Time (CET). More detailed instructions are
provided on the WHO/Essential Drugs and Medicines Policy web
site:
http://www.who.int/medicines/library/qsm/manual-on-marketing/exp
ressofinterest81.pdf
The text of the second expression of interest was also published in
the International Herald Tribune of Wednesday 1 August 2001.
Marthe M Everard
Technical Officer
Policy, Access, and Rational Use (PAR)
Essential Drugs and Medicines Policy (EDM)
World Health Organization
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://satellife.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.